Wockhardt Ltd.

WOCKPHARMA

₹1413.8

10.32% (132.3)

Market Cap

₹22,992 Cr.

P/E

0.00

Key Ratios

Edit Ratio's

Market cap

22,992 Cr

Prom Holding

49.08 %

ROE (%)

-1.08

ROCE (%)

4.29

Div Yield (%)

Sales

3,011 Cr

OPM (%)

12.42 %

Debt to Equity

0.43

Edit Ratio's

About

Wockhardt Limited is a global pharmaceutical and biotechnology organisation, providing afforda… Read more

Low

1110

52W Range

High

1869

Timeline

Key company specific updates

Company Timeline

Subscribe now for more updates

Custom financial statement

New

Edit rows

Forensics

8 Yes

Positive for this company

1 Neutral

Neutral for this company

8 No

Negative for this company

0 No Data

Insufficient data to analyse

Accounting & Shareholding

Contingent Liabilities

Company does not have significant contingent liabilities
Pledge

Promoters have not pledged a significant portion of their holding
Retail Holding

Retail has been selling the stock which is usually a good time to buy
Revenue Recognition

Company is converting accounting profit to cash
Promoter Holding

Promoter has not sold any shares in the last 90 days
Depreciation Effect

Company is depreciating a lower percentage of assets. this is contributing to an increase in net profit
Other Income

Other income component is making ratios of the company look optically better

Price & Performance

ROE

Asset turnover is responsible for roe increase over last 10 years
Share price

Share price has increased over last 10 years due to earnings
Working Capital

Working capital of the company seems to be under control
Balance Sheet Strength

Balance sheet of the company is strong. it shouldnt have solvency or liquidity issues
Capex vs ROCE

Roce of the company has decreased even without significant capex
Current vs Historic Valuation

Company is trading at a premium to 3yr historic valuations
Debt

Company might have issues servicing its debt
Sales Growth

Sales of the company has grown at a slow pace
Margin Stability

Margins of the company are volatile
ROCE Strength

Roce of the company is not consistently strong

Market Share

0.69 %

(as of Jul 22)

Historic

Anti - Diabetes - Market Share

0.05 %

(as of Jul 22)

Historic

Anti-Infectives - Market Share

0.01 %

(as of Aug 20)

Historic

Anti-Malarial - Market Share

0.05 %

(as of Nov 21)

Historic

Antineo Plastic - Market Share

4.31 %

(as of Nov 21)

Historic

Blood Related - Market Share

0 %

(as of Jul 22)

Historic

Cardiovascular - Market Share

0.03 %

(as of Nov 21)

Historic

Dermatology - Market Share

0.62 %

(as of Nov 21)

Historic

Endocrinology - Market Share

0.45 %

(as of Jul 22)

Historic

Gastro-Intestinal - Market Share

0.01 %

(as of Aug 20)

Historic

Gynecology - Market Share

11 %

(as of Mar 18)

Historic

Hospitals Market Share in Ireland

0.15 %

(as of Nov 21)

Historic

Neurological - Market Share

0.01 %

(as of Feb 18)

Historic

Ophthalmology - Market Share

0.11 %

(as of Nov 21)

Historic

Pain - Market Share

0.25 %

(as of Jul 22)

Historic

Pharmaceutical Sector - Market Share

0.01 %

(as of Jul 21)

Historic

Respiratory - Market Share

0 %

(as of Jul 22)

Historic

Sex Stimulants - Market Share

0.33 %

(as of Aug 20)

Historic

Stomatological - Market Share

0.14 %

(as of May 19)

Historic

Urology - Market Share

0 %

(as of Jul 22)

Historic

Vaccines - Market Share

0.73 %

(as of Jul 22)

Historic

Vitamin & Dietary Supplements - Market Share

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Asset Break-Up

Operational Metrics

Domestic Sales Growth - YoY (%)
Source
R&D as a % of Total Sales (%)
Source

Peer Comparison

Brands

Spasmo Proxyvon

Corporate Actions

Consolidated

DATE

DETAILS

Show Less

Suppliers

Shaily Engineering Plastics Ltd.
Borosil Renewables Ltd.
Responsive Industries Ltd.
Hindusthan National Glass & Industries Ltd.
Vivimed Labs Ltd.

FAQs on Wockhardt Ltd. Business

What does Wockhardt do?

Wockhardt Limited is a prominent Indian pharmaceutical and biotechnology company that prioritizes accessibility to high-quality medicines. They are active in Pharmaceuticals, Biotechnology, and Super Speciality Hospitals.

Who are the competitors of Wockhardt?

Wockhardt major competitors are Eris Lifesciences, Pfizer, Astrazeneca Pharma I, Alembic Pharma, Jubilant Pharmova, Caplin Point Lab, JB Chem & Pharma.
Market Cap of Wockhardt is ₹20,820 Crs.
While the median market cap of its peers are ₹21,644 Crs.

Is Wockhardt financially stable compared to its competitors?

Wockhardt seems to be less financially stable compared to its competitors.
Altman Z score of Wockhardt is 5.16 and is ranked 6 out of its 8 competitors.

View FAQ's On Shareprice

Global Leaders

Companies with a dominant global position in a product. Might be a sign of very strong moat.

Run Query

Superstar Favourites

Companies where superstar investors like Rakesh Jhunjhunwala, Asish Kacholia have invested

Run Query

Company Filing

	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Annual Report	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10
Earnings Release	May Aug	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun	Mar Jun Sep Dec	Jun Sep Dec
Investor Presentation	Jun	Sep Dec	Dec	Mar Dec	Dec					Mar	Mar Jun Sep Dec	Mar Jun Dec	Mar Jun Sep Dec	Jun Sep Dec
Conference Call	Mar			Dec							Mar Jun	Mar Nov	Jun Sep Dec	Sep Dec
Conference Call SummaryCon Call Summary Powered by Gemini

Discussions & Analysis

Wockhardt Ltd.

View The Discussion On ValuePickr - ValuePickr

Why Aditya Khemka Is Skeptical About Wockhardt's NCE Story - Accidental Investor Prince

Pharmaceuticals

How The Pharma Industry Works - PPFAS

Deep Dive into Pharma Sector - Omkara Capital

Pharma Compliance In-Depth - Amit Rajan

Nutraceuticals - The Next Gem of Healthcare Sector - Shuchi Nahar

Nutraceuticals- Industry Overview - Value Educator

GLP-1: The Drug Redefining Diabetes, Obesity, and Pharma’s Future - Perpetuity

Generic Opportunity for Indian Pharma Companies - Anish Moonka

Understanding the CDMO Sector - Will It Be The Next Megatrend - SOIC

Ideas Dashboard

Results

Timeline

Watchlist

Portfolio

Alerts

Stock Screener

Market

Raw Material

Wockhardt Ltd.

Wockhardt Ltd.

Key Ratios

About

Timeline

Company Timeline

Custom financial statement

Forensics

8 Yes

1 Neutral

8 No

0 No Data

Accounting & Shareholding

Contingent Liabilities

Pledge

Retail Holding

Revenue Recognition

Promoter Holding

Depreciation Effect

Other Income

Price & Performance

ROE

Share price

Working Capital

Balance Sheet Strength

Capex vs ROCE

Current vs Historic Valuation

Debt

Sales Growth

Margin Stability

ROCE Strength

Market Share

Revenue mix

Product Wise Break-Up

UNLOCK PREMIUM

Location Wise Break-Up

UNLOCK PREMIUM

Asset Break-Up

UNLOCK PREMIUM

Operational Metrics

Peer Comparison

Brands

Corporate Actions

Suppliers

FAQs on Wockhardt Ltd. Business

What does Wockhardt do?

Who are the competitors of Wockhardt?

Is Wockhardt financially stable compared to its competitors?

Similar Companies

Company Filing

Discussions & Analysis

SIGN UP FOR FREE